{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T10:35:11Z","timestamp":1774866911511,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015883","name":"Sociedad Espanola de Nefrologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015883","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.nefro.2021.02.001","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:48:56Z","timestamp":1615510136000},"page":"640-651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Contribuci\u00f3n de f\u00f3sforo y PTH al desarrollo de hipertrofia y fibrosis card\u00edaca en un modelo experimental de insuficiencia renal cr\u00f3nica"],"prefix":"10.1016","volume":"41","author":[{"given":"Laura","family":"Mart\u00ednez-Arias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Panizo-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Mart\u00edn-V\u00edrgala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Mart\u00edn-Carro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Fern\u00e1ndez-Villabrille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noelia","family":"Avello-Llano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Miguel-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Piedad","family":"Ruiz Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge B.","family":"Cannata-And\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Carrillo-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Naves-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefro.2021.02.001_bib0155","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0272-6386(12)80446-X","article-title":"Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease","volume":"19","author":"Delmez","year":"1992","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2021.02.001_bib0160","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2021.02.001_bib0165","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1046\/j.1523-1755.1999.07304.x","article-title":"Pathogenesis of secondary hyperparathyroidism","volume":"73","author":"Slatopolsky","year":"1999","journal-title":"Kidney Int Suppl."},{"key":"10.1016\/j.nefro.2021.02.001_bib0170","first-page":"16","article-title":"Role of phosphate retention in the progression of renal failure","volume":"122","author":"Loghman-Adham","year":"1993","journal-title":"J Lab Clin Med."},{"key":"10.1016\/j.nefro.2021.02.001_bib0175","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.ehj.2003.09.010","article-title":"Parathyroid hormone and left ventricular hypertrophy","volume":"24","author":"Saleh","year":"2003","journal-title":"Eur Heart J."},{"key":"10.1016\/j.nefro.2021.02.001_bib0180","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1681\/ASN.V4101814","article-title":"A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia","volume":"4","author":"Amann","year":"1994","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2021.02.001_bib0185","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1046\/j.1523-1755.2003.00864.x","article-title":"Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia","volume":"63","author":"Amann","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2021.02.001_bib0190","doi-asserted-by":"crossref","first-page":"F744","DOI":"10.1152\/ajprenal.00017.2015","article-title":"Fetuin-A decrease induced by a low-protein diet enhances vascular calcification in uremic rats with hyperphosphatemia","volume":"309","author":"Yamada","year":"2015","journal-title":"Am J Physiol Renal Physiol."},{"issue":"6 Pt 1","key":"10.1016\/j.nefro.2021.02.001_bib0195","doi-asserted-by":"crossref","first-page":"C1347","DOI":"10.1152\/ajpcell.1995.269.6.C1347","article-title":"Regulation of protein synthesis and degradation in adult ventricular cardiomyocytes","volume":"269","author":"Schl\u00fcter","year":"1995","journal-title":"Am J Physiol."},{"key":"10.1016\/j.nefro.2021.02.001_bib0200","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/ki.1987.293","article-title":"Secondary hyperparathyroidism and cardiac hypertrophy in hemodialysis patients","volume":"32","author":"London","year":"1987","journal-title":"Kidney Int."},{"issue":"1-3","key":"10.1016\/j.nefro.2021.02.001_bib0205","first-page":"67","article-title":"Effects of parathyroidectomy on left ventricular mass in patients with hyperparathyroidism","volume":"21","author":"Sato","year":"1995","journal-title":"Miner Electrolyte Metab."},{"key":"10.1016\/j.nefro.2021.02.001_bib0210","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/j.1523-1755.2004.66013.x","article-title":"Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure","volume":"66","author":"Neves","year":"2004","journal-title":"Kidney Int."},{"issue":"1-3","key":"10.1016\/j.nefro.2021.02.001_bib0215","first-page":"72","article-title":"Relation between parathyroid hormone and cardiac function in long-term hemodialysis patients","volume":"21","author":"Hara","year":"1995","journal-title":"Miner Electrolyte Metab."},{"key":"10.1016\/j.nefro.2021.02.001_bib0220","doi-asserted-by":"crossref","first-page":"p112","DOI":"10.1159\/000092244","article-title":"Effect of parathyroidectomy on cardiac fibrosis and apoptosis: possible role of aldosterone","volume":"103","author":"Rodr\u00edguez-Ayala","year":"2006","journal-title":"Nephron Physiol."},{"key":"10.1016\/j.nefro.2021.02.001_bib0225","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/gme.0b013e3181ce6874","article-title":"Differential effects of 17beta-estradiol and raloxifene on bone and lipid metabolism in rats with chronic kidney disease and estrogen insufficiency","volume":"17","author":"Naves-D\u00edaz","year":"2010","journal-title":"Menopause."},{"key":"10.1016\/j.nefro.2021.02.001_bib0230","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s002239900460","article-title":"The PTH-calcium relationship during a range of infused PTH doses in the parathyroidectomized rat","volume":"62","author":"Berdud","year":"1998","journal-title":"Calcif Tissue Int."},{"key":"10.1016\/j.nefro.2021.02.001_bib0235","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0272-6386(97)90283-3","article-title":"Rats with moderate renal failure show capillary deficit in heart but not skeletal muscle","volume":"30","author":"Amann","year":"1997","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2021.02.001_bib0240","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1093\/ndt\/gft268","article-title":"Vitamin D receptor activation, left ventricular hypertrophy and myocardial fibrosis","volume":"28","author":"Panizo","year":"2013","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2021.02.001_bib0245","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C[T]) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods."},{"key":"10.1016\/j.nefro.2021.02.001_bib0250","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/ndt\/gfy287","article-title":"High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease","volume":"34","author":"Carrillo-L\u00f3pez","year":"2018","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2021.02.001_bib0255","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/ndt\/gfm286","article-title":"High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients","volume":"22","author":"Voormolen","year":"2007","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2021.02.001_bib0260","first-page":"H941","article-title":"Use of tibial length to quantify cardiac hypertrophy: application in the aging rat","volume":"243","author":"Yin","year":"1982","journal-title":"Am J Physiol."},{"key":"10.1016\/j.nefro.2021.02.001_bib0265","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest."},{"key":"10.1016\/j.nefro.2021.02.001_bib0270","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/nm1275","article-title":"Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach","volume":"11","author":"Lautrette","year":"2005","journal-title":"Nat Med."},{"key":"10.1016\/j.nefro.2021.02.001_bib0275","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1097\/HJH.0b013e328357c049","article-title":"Submaximal suppression of parathyroid hormone ameliorates calcitriol-induced aortic calcification and remodeling and myocardial fibrosis in uremic rats","volume":"30","author":"Jung","year":"2012","journal-title":"J Hypertens."},{"key":"10.1016\/j.nefro.2021.02.001_bib0280","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/ndt\/gfr447","article-title":"Parathyroid hormone and phosphorus overload in uremia: impact on cardiovascular system","volume":"27","author":"Cust\u00f3dio","year":"2012","journal-title":"Nephrol Dial Transplant."},{"issue":"6 Pt 2","key":"10.1016\/j.nefro.2021.02.001_bib0285","first-page":"H1739","article-title":"Trophic effects of catecholamines and parathyroid hormone on adult ventricular cardiomyocytes","volume":"263","author":"Schl\u00fcter","year":"1992","journal-title":"Am J Physiol."},{"issue":"6 Pt 2","key":"10.1016\/j.nefro.2021.02.001_bib0290","first-page":"H1998","article-title":"Parathyroid hormone increases cytosolic calcium concentration in adult rat cardiac myocytes","volume":"264","author":"Smogorzewski","year":"1993","journal-title":"Am J Physiol."},{"key":"10.1016\/j.nefro.2021.02.001_bib0295","doi-asserted-by":"crossref","first-page":"e0231905","DOI":"10.1371\/journal.pone.0231905","article-title":"Fibrosis growth factor 23 is a promoting factor for cardiac fibrosis in the presence of transforming growth factor-\u03b21","volume":"15","author":"Kuga","year":"2020","journal-title":"PLoS One."},{"key":"10.1016\/j.nefro.2021.02.001_bib0300","doi-asserted-by":"crossref","first-page":"64649","DOI":"10.18632\/oncotarget.11623","article-title":"FGF23 promotes myocardial fibrosis in mice through activation of \u03b2-catenin","volume":"7","author":"Hao","year":"2016","journal-title":"Oncotarget."}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699521000333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699521000333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:55:20Z","timestamp":1759323320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211699521000333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0211699521000333"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2021.02.001","relation":{},"ISSN":["0211-6995"],"issn-type":[{"value":"0211-6995","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contribuci\u00f3n de f\u00f3sforo y PTH al desarrollo de hipertrofia y fibrosis card\u00edaca en un modelo experimental de insuficiencia renal cr\u00f3nica","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2021.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}